ELAVL1 and breast carcinoma: This study investigated the role of eltrombopag in regulating metastasis-related genes during breast cancer metastasis through HuR and verified the in vivo anti-metastasis activity of eltrombopag, which may accelerate the clinical application of HuR inhibitors for cancer therapy.